Earlier this month, health care products giant Johnson & Johnson was ordered to pay out roughly $72 million to one woman over allegations that the company’s talcum powder caused her ovarian cancer. According to one local news source reporting on the case, the case relied not just on the fact that Johnson & Johnson’s product caused the woman’s cancer but also on the fact that the company failed to warn customers of known risks associated with the product.
The Facts of the Case
The plaintiffs in the case were the family members of a woman who had used Johnson & Johnson’s “Shower to Shower” brand talcum powder for decades. The powder was marketed back in the 1970s as a safe feminine-hygiene product. However, there was evidence submitted at trial suggesting that Johnson & Johnson was aware of research indicating that the powder was not as safe as it was marketed to be. This decisive evidence was in the form of internal Johnson & Johnson documents.
Johnson & Johnson lawyers argued that there was no proof that the woman’s cancer was caused by the use of the company’s product. However, the jury rejected that argument and awarded the woman’s family roughly $72 million – an amount far-and-beyond the $22 million requested by the family.